For more information, please click here to download the course flyer
More than 1,400 Australians die from liver cancer each year. Mortality from liver cancer due to chronic hepatitis B (CHB) is increasing and without access to appropriate care, around 15-25% of people living with CHB will die from their condition. Timely diagnosis and clinical management, including antiviral therapy, can save lives.
This interactive workshop involves; online learning modules, in-depth presentations, case discussions, and facilitated group work giving attendees an opportunity to discuss practical strategies with peers and specialists.
GPs, Remote Medical Officers, Doctors working with Aboriginal & Torres Strait Islanders, Doctors working in custodial settings, Doctors who see patients who were born in endemic countries such as China, Vietnam, Korea, Doctors who see newly migrated people and refugees, Doctors who see patients from hepatitis B endemic countries, Drug and Alcohol Doctors
Conditions of registration:
Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before 17 March 2017 will not incur a cancellation fee. Cancellations received in writing after 17 March 2017 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM.
As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to email@example.com.